Cargando…
Use of Tumor Necrosis Factor-α Antagonists Is Associated With Attenuated IgG Antibody Response Against SARS-CoV-2 in Vaccinated Patients With Inflammatory Bowel Disease
INTRODUCTION: Patients with Inflammatory Bowel Disease (IBD) frequently receive immunomodulating treatment, which may render them at increased risk of an attenuated immune response upon vaccination. In this study, we assessed the effects of different types of commonly prescribed immunosuppressive me...
Autores principales: | Otten, Antonius T., Bourgonje, Arno R., Horinga, Petra P., van der Meulen, Hedwig H., Festen, Eleonora A. M., van Dullemen, Hendrik M., Weersma, Rinse K., van Leer-Buter, Coretta C., Dijkstra, Gerard, Visschedijk, Marijn C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294156/ https://www.ncbi.nlm.nih.gov/pubmed/35865529 http://dx.doi.org/10.3389/fimmu.2022.920333 |
Ejemplares similares
-
Isotype-specific Antibody Responses to Mycobacterium avium
paratuberculosis Antigens Are Associated With the Use of Biologic Therapy in
Inflammatory Bowel Disease
por: van der Sloot, Kimberley W J, et al.
Publicado: (2020) -
Serological biomarkers of type I, III and IV collagen turnover are associated with the presence and future progression of stricturing and penetrating Crohnʼs disease
por: Bourgonje, Arno R., et al.
Publicado: (2022) -
Proteomic analyses do not reveal subclinical inflammation in fatigued patients with clinically quiescent inflammatory bowel disease
por: Bourgonje, Arno R., et al.
Publicado: (2022) -
Serological Biomarkers of Extracellular Matrix Turnover and Neutrophil Activity Are Associated with Long-Term Use of Vedolizumab in Patients with Crohn’s Disease
por: Alexdottir, Marta S., et al.
Publicado: (2022) -
Serological Biomarkers of Intestinal Collagen Turnover Identify Early Response to Infliximab Therapy in Patients With Crohn’s Disease
por: Alexdottir, Marta S., et al.
Publicado: (2022)